Bausch Health Companies Inc. (BHC)
NYSE
Closed
Oct 9, 2026
Day's Range
6.0252 wk Range
4.33Profile - BHC - Bausch Health Companies Inc.
Profile
Mic Code
XNYS
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
20.30K
Bausch Health Companies Inc. is a diversified specialty pharmaceutical and medical device company focused on developing, manufacturing, and marketing healthcare products across multiple therapeutic areas. Bausch Health serves the gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals, and eye health markets, with a portfolio that includes branded, generic, and over-the-counter medicines as well as medical devices. Its operations are organized around products and services used in treating conditions such as digestive disorders, skin diseases, neurological conditions, and vision-related care. The company also supports hospital and clinic needs through its medical device and ophthalmic businesses. Headquartered in Laval, Quebec, Bausch Health plays a significant role in the global healthcare market by supplying therapies and devices used by patients, physicians, and healthcare providers across the United States and international markets.
Profile Details
Type
Common Stock
Address
2150 St. Elzéar Blvd. West
City
Laval
State
QC
Zip
H7L 4A8
Country
Canada
Phone
514 744 6792
Key Executives - BHC - Bausch Health Companies Inc.
Key executives
Cross Listings - BHC - Bausch Health Companies Inc.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
